化学
代谢物
糖尿病肾病
肾
肠道菌群
氧化三甲胺
药理学
链脲佐菌素
糖尿病
炎症
巨噬细胞极化
胆汁酸
代谢组学
平衡
下调和上调
内分泌学
内科学
癌症研究
生物化学
代谢组
促炎细胞因子
胰岛素抵抗
微生物群
细胞生物学
肾功能
作者
Qingqing Zhang,Ziheng Zhang,Nannan Song,Chongzheng Pang,Fanglong Hu,Jianpeng Li,C Q Liu,Aiya Zhao,Jinting Chen,Baohua Chen,Baoku Li,Shaoyong Zhuang,Chengyan Zhou
标识
DOI:10.1016/j.jpha.2026.101705
摘要
Diabetic nephropathy (DN), a condition characterized by persistent inflammatory responses, represents one of the most serious complications of diabetes mellitus; however, effective treatment strategies for DN remain limited. This study aimed to explore the potential therapeutic effects of procyanidin B2 (PB2) in mice with DN induced by high-fat diet (HFD) and streptozotocin (STZ). Tissue pathology was evaluated by histopathological analysis. Microbiome sequencing, targeted metabolomics, quantitative real-time polymerase chain reaction (qRT‒PCR), western blotting (WB), and immunohistochemistry (IHC) were combined to explore alterations in gut-derived trimethylamine N -oxide (TMAO) and the underlying mechanisms through which PB2 in prevents DN. Finally, TMAO rescue experiment and fecal microbiota transplantation (FMT) was performed to validate the regulatory effects of TMAO and the gut microbiota on DN. The results indicated that PB2 significantly improved liver and kidney function and intestinal-barrier integrity via the gut–liver–kidney axis while maintaining cholesterol homeostasis and restoring bile acid (BA) metabolism. Notably, PB2 significantly modulated the gut microbiota and markedly decreased circulating TMAO levels by targeting the trimethylamine/flavin-containing monooxygenase 3/TMAO axis. TMAO promoted renal injury by multiple signaling pathways, thereby inducing ferroptosis, stress–autophagy axis, macrophage polarization. Furthermore, TMAO supplementation and FMT verified the importance of the gut-flora-dependent metabolite TMAO in the protective role of PB2 against DN. Collectively, these findings clarify the anti-DN effects of PB2, which occur through a novel gut–liver–kidney axis-based mechanism, and suggest that PB2 is a promising therapeutic option for DN through the modulation of kidney inflammation.
科研通智能强力驱动
Strongly Powered by AbleSci AI